Electrocore LLC Total Liabilities
Electrocore LLC total liabilities. Based on the latest financial reports, Electrocore LLC (ECOR) has total liabilities worth $19.85 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Electrocore LLC to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Electrocore LLC (2016–2025)
Total liabilities of Electrocore LLC from 2016 to 2025. This chart illustrates how Electrocore LLC's total liabilities have evolved over time, based on quarterly financial data.
Electrocore LLC Competitors by Total Liabilities
The table below lists competitors of Electrocore LLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
KPS Corporation
KQ:256940
|
Korea | ₩123.69 Billion |
|
Alterity Therapeutics Limited
F:PBN
|
Germany | €2.65 Million |
|
Frontier Lithium Inc
V:FL
|
Canada | CA$35.81 Million |
|
MasterBeef Group Ordinary Shares
NASDAQ:MB
|
USA | $256.61 Million |
|
Cauldron Energy Ltd
AU:CXU
|
Australia | AU$1.01 Million |
|
Johnson Chemical Pharmaceutical Works Co Ltd
TWO:4747
|
Taiwan | NT$820.26 Million |
|
Austral Gold Ltd
V:AGLD
|
Canada | CA$67.17 Million |
|
High Tech Pharm Co. Ltd
KQ:106190
|
Korea | ₩12.57 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Electrocore LLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Electrocore LLC's balance sheet.
Liquidity & Leverage Metrics
Electrocore LLC Total Liabilities Ratios Explained
Electrocore LLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -7.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Electrocore LLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Electrocore LLC (2016–2025)
The table below shows the annual total liabilities of Electrocore LLC from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $20.38 Million | +57.62% |
| 2024-12-31 | $12.93 Million | +49.27% |
| 2023-12-31 | $8.66 Million | +12.91% |
| 2022-12-31 | $7.67 Million | +24.01% |
| 2021-12-31 | $6.18 Million | -21.45% |
| 2020-12-31 | $7.87 Million | -25.47% |
| 2019-12-31 | $10.56 Million | +44.35% |
| 2018-12-31 | $7.32 Million | -94.31% |
| 2017-12-31 | $128.70 Million | +108.67% |
| 2016-12-31 | $61.68 Million | -- |
About Electrocore LLC
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic… Read more